Bentham Science Logo

Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 19, 3 Issues, 2019
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access

Manuscript Transfer Facility

If the author’s manuscript is assessed as inappropriate to be published in his/her preferred journal, our editorial team may help the author in transferring the submission to a more appropriate Bentham Journal, through Bentham’s Manuscript Transfer Facility.

Transfer of Submission

Transfer of submission with Bentham’s Manuscript Transfer Facility is very simple.

Step 1.

The Author receives the transfer proposal by email - the transfer process is initiated by an affirmative response from the author to our transfer proposal.

Step 2.

The Authors’ manuscript is transferred to a suitable journal for initial editorial scrutiny.

Step 3.

The Author then receives an editorial decision from the journal.

Selection of another Journal

The Author is free to choose to submit the manuscript to a new journal by declining our transfer offer.

Our aim is to facilitate and develop rapid, effective and truly innovative solutions to facilitate our valued authors by enabling more options and better services to improve the publication process.


Editor-in-Chief

Garry X. Shen
University of Manitoba
Winnipeg, MB
Canada

Biography View Full Editorial Board

Journal History

Cardiovascular and Hematological Disorders-drug Targets was launched in 2001. Dr. Garry X. Shen serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


New eBook

Frontiers in Clinical Drug Research-Hematology



You can view the contents of this eBook [here] or purchase it [here].

Related Journals

Related eBooks

eBooks Catalog